Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,488
NCT00248183
A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)
Phase: Phase 3
Role: Lead Sponsor
Start: Aug 31, 2005
Completion: Jun 30, 2006
NCT00345774
Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Phase: Phase 2
Start: Jun 30, 2006
Completion: Jun 30, 2007
NCT00384423
Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
Start: Oct 31, 2006
Completion: Not specified
NCT00448292
A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder
Start: Mar 31, 2007
Completion: Nov 30, 2007
NCT00672945
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
Start: Apr 30, 2008
NCT00677872
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Start: May 31, 2008
NCT00693004
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease